NM_052953.4:c.-161+20504G>A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_052953.4(LRRC3B):c.-161+20504G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.219 in 152,100 control chromosomes in the GnomAD database, including 4,493 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.22 ( 4493 hom., cov: 32)
Consequence
LRRC3B
NM_052953.4 intron
NM_052953.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 1.85
Publications
3 publications found
Genes affected
LRRC3B (HGNC:28105): (leucine rich repeat containing 3B) The protein encoded by this gene is a tumor suppressor, with lowered expression levels found in gastric, renal, colorectal, lung, and breast cancer tissues. The promoter of this gene is frequently hypermethylated in these cancer tissues, although the hypermethylation does not appear to be the cause of the reduced expression of this gene. Several transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Dec 2015]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.449 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.219 AC: 33255AN: 151982Hom.: 4484 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
33255
AN:
151982
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.219 AC: 33302AN: 152100Hom.: 4493 Cov.: 32 AF XY: 0.222 AC XY: 16530AN XY: 74358 show subpopulations
GnomAD4 genome
AF:
AC:
33302
AN:
152100
Hom.:
Cov.:
32
AF XY:
AC XY:
16530
AN XY:
74358
show subpopulations
African (AFR)
AF:
AC:
14175
AN:
41478
American (AMR)
AF:
AC:
2983
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
726
AN:
3466
East Asian (EAS)
AF:
AC:
2398
AN:
5162
South Asian (SAS)
AF:
AC:
1365
AN:
4816
European-Finnish (FIN)
AF:
AC:
1557
AN:
10592
Middle Eastern (MID)
AF:
AC:
58
AN:
292
European-Non Finnish (NFE)
AF:
AC:
9272
AN:
67970
Other (OTH)
AF:
AC:
479
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1233
2467
3700
4934
6167
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
334
668
1002
1336
1670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1138
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.